{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:38:44Z","timestamp":1790131124747,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008810","name":"NSW Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.hrthm.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T09:27:55Z","timestamp":1707298075000},"page":"939-949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adeno-associated virus\u2013mediated gene therapy for cardiac tachyarrhythmia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0720-077X","authenticated-orcid":false,"given":"Juan","family":"Mundisugih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Kizana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.02.001_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.02.001_bib2","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2024.02.001_bib3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.clinthera.2020.09.001","article-title":"Gene and cell therapy for cardiac arrhythmias","volume":"42","author":"Ravindran","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.hrthm.2024.02.001_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.02.001_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/circ.146.suppl_1.11117","article-title":"Phase 1 Danon disease results: the first single dose intravenous (IV) gene therapy (RP-A501) with recombinant adeno-associated virus (AAV9:LAMP2B) for a monogenic cardiomyopathy [Abstract]","volume":"146","author":"Rossano","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.02.001_bib7","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2024.02.001_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","article-title":"Pooling of animal experimental data reveals influence of study design and publication bias","volume":"35","author":"Macleod","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2024.02.001_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacep.2021.10.010","article-title":"Autonomic afferent dysregulation in atrial fibrillation","volume":"8","author":"Malik","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.fmre.2022.05.002","article-title":"Long-term amelioration of an early-onset familial atrial fibrillation model with AAV-mediated in\u00a0vivo gene therapy","volume":"2","author":"Hu","year":"2022","journal-title":"Fundam Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib12","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.12659\/MSM.904824","article-title":"Prevention of atrial fibrillation by using sarcoplasmic reticulum calcium ATPase pump overexpression in a rabbit model of rapid atrial pacing","volume":"23","author":"Wang","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.hrthm.2024.02.001_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.114.012657","article-title":"Upregulation of K2P3.1 K+ current causes action potential shortening in patients with chronic atrial fibrillation","volume":"132","author":"Schmidt","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.02.001_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007465","article-title":"Genetic ablation of TASK-1 (tandem of P domains in a weak inward rectifying K+ channel\u2013related acid-sensitive K+ channel-1) (K2P3.1) K+ channels suppresses atrial fibrillation and prevents electrical remodeling","volume":"12","author":"Schmidt","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13577-018-0208-z","article-title":"Atrial overexpression of microRNA-27b attenuates angiotensin II\u2013induced atrial fibrosis and fibrillation by targeting ALK5","volume":"31","author":"Wang","year":"2018","journal-title":"Hum Cell"},{"key":"10.1016\/j.hrthm.2024.02.001_bib16","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.02.001_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12872-019-1013-7","article-title":"The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hrthm.2024.02.001_bib18","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.jacc.2016.08.074","article-title":"Alcohol and atrial fibrillation: a sobering review","volume":"68","author":"Voskoboinik","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166483","article-title":"Icariin attenuates excessive alcohol consumption\u2013induced susceptibility to atrial fibrillation through SIRT3 signaling","volume":"1868","author":"Yu","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.hrthm.2024.02.001_bib20","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/cvr\/cvaa239","article-title":"Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control","volume":"117","author":"Rathjens","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/cphy.c140048","article-title":"The dystrophin complex: structure, function, and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189469","article-title":"Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure","volume":"12","author":"Prado","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2024.02.001_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41434-022-00348-z","article-title":"Forced activation of dystrophin transcription by CRISPR\/dCas9 reduced arrhythmia susceptibility via restoring membrane Nav1.5 distribution","volume":"30","author":"Zhang","year":"2023","journal-title":"Gene Ther"},{"key":"10.1016\/j.hrthm.2024.02.001_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009598","article-title":"Primary effect of SERCA2a gene transfer on conduction reserve in chronic myocardial infarction","volume":"7","author":"Motloch","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.02.001_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41569-019-0221-2","article-title":"The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies","volume":"16","author":"Herring","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00395-022-00939-2","article-title":"Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model","volume":"117","author":"Zhou","year":"2022","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/138920208784340768","article-title":"Molecular mechanisms of inherited arrhythmias","volume":"9","author":"Wolf","year":"2008","journal-title":"Curr Genomics"},{"key":"10.1016\/j.hrthm.2024.02.001_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2013.55","article-title":"Clinical utility gene card for: catecholaminergic polymorphic ventricular tachycardia (CPVT)","volume":"22","author":"Napolitano","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hrthm.2024.02.001_bib29","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/hmg\/dds104","article-title":"Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human","volume":"21","author":"Roux-Buisson","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2024.02.001_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.117.310882","article-title":"Allele-specific silencing of mutant mRNA rescues ultrastructural and arrhythmic phenotype in mice carriers of the R4496C mutation in the ryanodine receptor gene (RYR2)","volume":"121","author":"Bongianino","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/CIRCRESAHA.118.313369","article-title":"In\u00a0vivo Ryr2 editing corrects catecholaminergic polymorphic ventricular tachycardia","volume":"123","author":"Pan","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41419-021-04337-9","article-title":"\u201cRyanopathies\u201d and RyR2 dysfunctions: can we further decipher them using in\u00a0vitro human disease models?","volume":"12","author":"Sleiman","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.hrthm.2024.02.001_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.111.263939","article-title":"Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias","volume":"110","author":"Denegri","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib34","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/CIRCULATIONAHA.113.006901","article-title":"Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age","volume":"129","author":"Denegri","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.02.001_bib35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.hrthm.2017.03.025","article-title":"Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models","volume":"14","author":"Kurtzwald-Josefson","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.02.001_bib36","doi-asserted-by":"crossref","first-page":"e2393","DOI":"10.1038\/cddis.2016.304","article-title":"Adeno-associated virus\u2013mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Lodola","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.hrthm.2024.02.001_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymthe.2019.09.012","article-title":"Interplay between triadin and calsequestrin in the pathogenesis of CPVT in the mouse","volume":"28","author":"Cacheux","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.hrthm.2024.02.001_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008155","article-title":"Gene transfer of engineered calmodulin alleviates ventricular arrhythmias in a calsequestrin-associated mouse model of catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Liu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.02.001_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca2+\/calmodulin-dependent kinase II","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.02.001_bib40","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1111\/febs.12337","article-title":"Calmodulin in a heartbeat","volume":"280","author":"Sorensen","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.hrthm.2024.02.001_bib41","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.114.300569","article-title":"Role of RyR2 phosphorylation in heart failure and arrhythmias","volume":"114","author":"Houser","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib42","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.02.001_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.stemcr.2021.12.016","article-title":"Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes","volume":"17","author":"Inoue","year":"2022","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.hrthm.2024.02.001_bib44","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s44161-023-00370-3","article-title":"Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics","volume":"2","author":"Bradford","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s44161-023-00378-9","article-title":"Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy","volume":"2","author":"Kyriakopoulou","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib46","article-title":"Cardiac AAV9:PKP2 gene therapy reduces ventricular arrhythmia, reverses adverse remodeling, and reduces mortality in a mouse model of ARVC","volume":"23","author":"Wu","year":"2023","journal-title":"Preprint. Posted online May"},{"key":"10.1016\/j.hrthm.2024.02.001_bib47","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2024.02.001_bib48","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2024.02.001_bib49","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1093\/cvr\/cvac021","article-title":"Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact","volume":"118","author":"Dave","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/CIRCRESAHA.122.322294","article-title":"GJA1-20k rescues Cx43 localization and arrhythmias in arrhythmogenic cardiomyopathy","volume":"132","author":"Palatinus","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf3274","article-title":"Loss-of-function mutations in the co-chaperone protein BAG5 cause dilated cardiomyopathy requiring heart transplantation","volume":"14","author":"Hakui","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hrthm.2024.02.001_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.str.2010.01.004","article-title":"The C-terminal BAG domain of BAG5 induces conformational changes of the Hsp70 nucleotide-binding domain for ADP-ATP exchange","volume":"18","author":"Arakawa","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.hrthm.2024.02.001_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003121","article-title":"Clinical spectrum of PRKAG2 syndrome","volume":"9","author":"Porto","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib54","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/cr.2016.101","article-title":"Genome editing with CRISPR\/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome","volume":"26","author":"Xie","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.hrthm.2024.02.001_bib55","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.02.001_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.hrthm.2024.02.001_bib57","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1074\/jbc.M709721200","article-title":"Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5","volume":"283","author":"Wu","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2024.02.001_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf3136","article-title":"Gene therapy targeting protein trafficking regulator MOG1 in mouse models of Brugada syndrome, arrhythmias, and mild cardiomyopathy","volume":"14","author":"Yu","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hrthm.2024.02.001_bib59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCULATIONAHA.123.065624","article-title":"In\u00a0vivo base editing of Scn5a rescues type 3 long QT syndrome in mice","volume":"149","author":"Qi","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.02.001_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41467-022-28251-6","article-title":"Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy","volume":"13","author":"Nguyen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2024.02.001_bib61","doi-asserted-by":"crossref","first-page":"H1178","DOI":"10.1152\/ajpheart.00287.2023","article-title":"Prokaryotic voltage-gated sodium channels are more effective than endogenous Nav1.5 channels in rescuing cardiac action potential conduction: an in silico study","volume":"325","author":"Needs","year":"2023","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2024.02.001_bib62","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/hmg\/ddab127","article-title":"Phenotypic recapitulation and correction of desmoglein-2\u2013deficient cardiomyopathy using human-induced pluripotent stem cell\u2013derived cardiomyocytes","volume":"30","author":"Shiba","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2024.02.001_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.omtm.2023.08.010","article-title":"Development of new adeno-associated virus capsid variants for targeted gene delivery to human cardiomyocytes","volume":"30","author":"Kok","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.hrthm.2024.02.001_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","article-title":"Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle","volume":"28","author":"Asokan","year":"2010","journal-title":"Nat Biotechnol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T22:58:24Z","timestamp":1716937104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1547527124001115"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.02.001","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adeno-associated virus\u2013mediated gene therapy for cardiac tachyarrhythmia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}